| Date Filed | Type | Description |
| 10/03/2023 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,533 restricted stock units
@ $0 |
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,533 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 13,930 options
@ $3.16, valued at
$44k
Granted 10,133 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 2,859 restricted stock units
@ $0 |
|
| 02/04/2022 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 15,128 options
@ $2.8, valued at
$42.4k
Granted 11,436 options to buy
@ $0 |
|
| 01/04/2022 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 751 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 751 restricted stock units
@ $0 |
|
| 04/01/2021 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 751 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Granted 4,443 options
@ $6.81, valued at
$30.3k
Granted 3,005 restricted stock units
@ $0 |
|
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2020 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Monopar Therapeutics|
Txns:
| Exercised 322 restricted stock units
@ $0 |
|
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/21/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 5,021 shares
@ $0
Granted 18,996 options to buy
@ $11.55, valued at
$219.4k
|
|
| 03/25/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 20,033 shares
@ $11.6171, valued at
$232.7k
Exercised 20,033 options to buy
@ $3.54, valued at
$70.9k
|
|
| 03/18/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,021 shares
@ $11.7106, valued at
$351.6k
Exercised 30,021 options to buy
@ $3.54, valued at
$106.3k
|
|
| 02/25/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.5218, valued at
$285.7k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 02/19/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.3702, valued at
$281.1k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 02/11/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Granted 1,674 shares
@ $0
Granted 6,332 options to buy
@ $9.36, valued at
$59.3k
|
|
| 01/26/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.4523, valued at
$283.6k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 01/20/2015 |
4
| STARR CHRISTOPHER M (Director) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.7324, valued at
$292k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 12/23/2014 |
4
| STARR CHRISTOPHER M (CEO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.0016, valued at
$270k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 12/17/2014 |
4
| STARR CHRISTOPHER M (CEO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $8.1528, valued at
$244.6k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
| 11/25/2014 |
4
| STARR CHRISTOPHER M (CEO) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Sold 30,000 shares
@ $9.9657, valued at
$299k
Exercised 30,000 options to buy
@ $3.54, valued at
$106.2k
|
|
|